{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:45:12Z","timestamp":1791999912625,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["numberSZZYSM202206005"],"award-info":[{"award-number":["numberSZZYSM202206005"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024B03J1281"],"award-info":[{"award-number":["2024B03J1281"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.dmd.2026.100352","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:04:12Z","timestamp":1782774252000},"page":"100352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of CYP3A5 and CYP3A4 in the metabolism and toxicity of 10-hydroxyl mesaconitine, a new potential toxicity marker of Radix Aconiti Lateralis Preparata (Fuzi), in vitro and in vivo"],"prefix":"10.1016","volume":"54","author":[{"given":"Yu","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dmd.2026.100352_bib1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jep.2013.01.025","article-title":"Development and assessment of a complete-detoxication strategy for Fuzi (lateral root of Aconitum carmichaeli) and its application in rheumatoid arthritis therapy","volume":"146","author":"Tong","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.dmd.2026.100352_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9728957","article-title":"Efficacy and safety of Fuzi formulae on the treatment of heart failure as complementary therapy: a systematic review and meta-analysis of high-quality randomized controlled trials","volume":"2019","author":"Yang","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"10.1016\/j.dmd.2026.100352_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02167-5","article-title":"Revealing the efficacy-toxicity relationship of Fuzi in treating rheumatoid arthritis by systems pharmacology","volume":"11","author":"Feng","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.dmd.2026.100352_bib4","first-page":"720","article-title":"Anaysis of alkaloids in Aconiti lateralis radix Praeparata and prediction of their mechanism in the treatment of cancer","volume":"37","author":"Lu","year":"2021","journal-title":"J Nanjing Univ Tradit Chin Med"},{"key":"10.1016\/j.dmd.2026.100352_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115693","article-title":"Fuzi decoction treats chronic heart failure by regulating the gut microbiota, increasing the short-chain fatty acid levels and improving metabolic disorders","volume":"236","author":"Gao","year":"2023","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.dmd.2026.100352_bib6","article-title":"A review of Aconiti Lateralis Radix Praeparata (Fuzi) for kidney disease: phytochemistry, toxicology, herbal processing, and pharmacology","volume":"15","author":"Wu","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100352_bib7","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s42003-024-06801-6","article-title":"Alkaloids of Aconiti Lateralis Radix Praeparata inhibit growth of non-small cell lung cancer by regulating PI3K\/Akt-mTOR signaling and glycolysis","volume":"7","author":"Zhang","year":"2024","journal-title":"Commun Biol"},{"issue":"12","key":"10.1016\/j.dmd.2026.100352_bib8","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1177\/0960327111407224","article-title":"Causes and prevention of herb-induced aconite poisonings in Asia","volume":"30","author":"Chan","year":"2011","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.dmd.2026.100352_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115838","article-title":"Ethnopharmacological use, pharmacology, toxicology, phytochemistry, and progress in Chinese crude drug processing of the lateral root of Aconitum carmichaelii Debeaux. (Fuzi): a review","volume":"301","author":"Wang","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.dmd.2026.100352_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116160","article-title":"Chemical constituents, pharmacological effects, toxicology, processing and compatibility of Fuzi (lateral root of Aconitum carmichaelii Debx): a review","volume":"307","author":"He","year":"2023","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"10.1016\/j.dmd.2026.100352_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/toxins10100391","article-title":"Relationships between the toxicities of Radix Aconiti Lateralis Preparata (Fuzi) and the toxicokinetics of its main diester-diterpenoid alkaloids","volume":"10","author":"Yang","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.dmd.2026.100352_bib12","first-page":"526","article-title":"Research on Aconitum carmichaelii Debx in China XIII. Alkaloids in Aconitum kusnezoffii","volume":"9","author":"Wang","year":"1980","journal-title":"Acta Pharm Sin"},{"issue":"1","key":"10.1016\/j.dmd.2026.100352_bib13","first-page":"71","article-title":"Study on liposoluble alkaloids of Aconitum carmichaeli Debx from Sichuan Jiangyou","volume":"20","author":"Wang","year":"1985","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.dmd.2026.100352_bib14","series-title":"Pharmacopoeia of the People's Republic of China (Part 1)","year":"2020"},{"key":"10.1016\/j.dmd.2026.100352_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115332","article-title":"Mdr1a, Bcrp and Mrp2 regulate the efficacy and toxicity of mesaconitine and hypaconitine by altering their tissue accumulation and in vivo residence","volume":"409","author":"Li","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.dmd.2026.100352_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115879","article-title":"Neoline, fuziline, songorine and 10-OH mesaconitine are potential quality markers of Fuzi: In vitro and in vivo explorations as well as pharmacokinetics, efficacy and toxicity evaluations","volume":"303","author":"Li","year":"2023","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100352_bib17","first-page":"45","article-title":"Study on Fuzi-VI. Pharmacological effects of aconitine and its related compounds in Fuzi","volume":"8","author":"Zhou","year":"1992","journal-title":"Pharmacol Clin Chin Mater Med"},{"key":"10.1016\/j.dmd.2026.100352_bib18","first-page":"41","article-title":"Study on Fuzi-VI. Pharmacological effects of aconitine and its related compounds in Fuzi (continued)","volume":"6","author":"Zhou","year":"1992","journal-title":"Pharmacol Clin Chin Mater Med"},{"issue":"12","key":"10.1016\/j.dmd.2026.100352_bib19","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/bmc.1607","article-title":"Screening and analysis of aconitum alkaloids and their metabolites in rat urine after oral administration of aconite roots extract using LC-TOFMS-based metabolomics","volume":"25","author":"Tan","year":"2011","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.dmd.2026.100352_bib20","article-title":"In vivo and in vitro metabolites from the main diester and monoester diterpenoid alkaloids in a traditional Chinese herb, the Aconitum species","volume":"2015","author":"Zhang","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"10.1016\/j.dmd.2026.100352_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4049","article-title":"Chemical UPLC-ESI-MS\/MS profiling of aconitum alkaloids and their metabolites in rat plasma and urine after oral administration of Aconitum carmichaelii Debx, Root extract","volume":"32","author":"Zhang","year":"2018","journal-title":"Biomed Chromatogr"},{"issue":"1","key":"10.1016\/j.dmd.2026.100352_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.toxlet.2011.01.019","article-title":"Involvement of CYP3A4\/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes","volume":"202","author":"Tang","year":"2011","journal-title":"Toxicol Lett"},{"issue":"1","key":"10.1016\/j.dmd.2026.100352_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/00498254.2010.524950","article-title":"Characterization of metabolites and human P450 isoforms involved in the microsomal metabolism of mesaconitine","volume":"41","author":"Ye","year":"2011","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.dmd.2026.100352_bib24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.toxlet.2011.04.015","article-title":"Microsomal cytochrome P450-mediated metabolism of hypaconitine, an active and highly toxic constituent derived from Aconitum species","volume":"204","author":"Ye","year":"2011","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.dmd.2026.100352_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/941093","article-title":"Monoester-diterpene aconitum alkaloid metabolism in human liver microsomes: predominant role of CYP3A4 and CYP3A5","volume":"2013","author":"Ye","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.dmd.2026.100352_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116024","article-title":"Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: one of the possible explanations for clinical adverse reactions","volume":"445","author":"Li","year":"2022","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.dmd.2026.100352_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113989","article-title":"Clinical poisoning events involving yunaconitine may be highly correlated with metabolism-based interactions: a critical role of CYP3A4","volume":"179","author":"Li","year":"2023","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.dmd.2026.100352_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.641530","article-title":"Uncovering modern clinical applications of Fuzi and Fuzi-based formulas: a nationwide descriptive study with market basket analysis","volume":"12","author":"Tai","year":"2021","journal-title":"Front Pharmacol"},{"issue":"77","key":"10.1016\/j.dmd.2026.100352_bib29","first-page":"172","article-title":"Analysis of the efficacy of Si Ni Tang combined with diltiazem in the treatment of variant angina pectoris","volume":"5","author":"Xiao","year":"2018","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.dmd.2026.100352_bib30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.dmd.2026.100352_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/dmd.115.067900","article-title":"Interindividual variability in cytochrome P450-mediated drug metabolism","volume":"44","author":"Tracy","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.dmd.2026.100352_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/bdd.568","article-title":"Pharmacokinetics and metabolism of diltiazem in rats: comparing single vs repeated subcutaneous injections in vivo","volume":"28","author":"Yeung","year":"2007","journal-title":"Biopharm Drug Dispos"},{"issue":"3","key":"10.1016\/j.dmd.2026.100352_bib33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jep.2005.11.027","article-title":"Preliminary toxicity and phytochemical studies of the stem bark aqueous extract of Musanga cecropioides in rats","volume":"105","author":"Adeneye","year":"2006","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2026.100352_bib34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00003088-199733020-00003","article-title":"Drug interactions with grapefruit juice","volume":"33","author":"Ameer","year":"1997","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"10.1016\/j.dmd.2026.100352_bib35","doi-asserted-by":"crossref","first-page":"PL135","DOI":"10.1016\/S0024-3205(98)00013-7","article-title":"Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine","volume":"62","author":"Chan","year":"1998","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.dmd.2026.100352_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00228-012-1388-1","article-title":"Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activity","volume":"69","author":"Fuchs","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2026.100352_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00008571-200004000-00001","article-title":"Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes","volume":"10","author":"Streetman","year":"2000","journal-title":"Pharmacogenetics"},{"issue":"9","key":"10.1016\/j.dmd.2026.100352_bib39","first-page":"1205","article-title":"Genetic polymorphism of cytochrome P450 3A5 in Chinese","volume":"29","author":"Chou","year":"2001","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.dmd.2026.100352_bib40","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1124\/dmd.118.083295","article-title":"Advances in engineered human liver platforms for drug metabolism studies","volume":"46","author":"Underhill","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"2-3","key":"10.1016\/j.dmd.2026.100352_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.toxlet.2012.11.011","article-title":"The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells","volume":"216","author":"Ye","year":"2013","journal-title":"Toxicol Lett"},{"issue":"4","key":"10.1016\/j.dmd.2026.100352_bib42","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3109\/03602532.2011.597401","article-title":"In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences","volume":"43","author":"Komura","year":"2011","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.dmd.2026.100352_bib43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-0716-1554-6_7","article-title":"Crystal structures of drug-metabolizing CYPs","volume":"2342","author":"Estrada","year":"2021","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100352_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2133\/dmpk.25.93","article-title":"Species differences in mechanism-based inactivation of CYP3A in humans, rats and mice","volume":"25","author":"Aueviriyavit","year":"2010","journal-title":"Drug Metab Pharmacokinet"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626006215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626006215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:53:44Z","timestamp":1791996824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626006215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0090955626006215"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100352","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of CYP3A5 and CYP3A4 in the metabolism and toxicity of 10-hydroxyl mesaconitine, a new potential toxicity marker of Radix Aconiti Lateralis Preparata (Fuzi), in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100352"}}